|
MYEF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.564500E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.675800E-02 |
| Normal-vs-Stage2 |
9.670600E-01 |
| Normal-vs-Stage3 |
2.364700E-04 |
| Normal-vs-Stage4 |
2.23109999999416E-05 |
| Stage1-vs-Stage2 |
2.561400E-01 |
| Stage1-vs-Stage3 |
9.403500E-03 |
| Stage1-vs-Stage4 |
2.039700E-03 |
| Stage2-vs-Stage3 |
8.363100E-03 |
| Stage2-vs-Stage4 |
3.356500E-03 |
| Stage3-vs-Stage4 |
4.991000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.613100E-04 |
| Normal-vs-AfricanAmerican |
2.631600E-01 |
| Normal-vs-Asian |
6.428000E-01 |
| Caucasian-vs-AfricanAmerican |
3.217800E-01 |
| Caucasian-vs-Asian |
1.508000E-01 |
| AfricanAmerican-vs-Asian |
2.957600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.97150000000357E-05 |
| Normal-vs-Female |
4.563000E-01 |
| Male-vs-Female |
2.360000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.098800E-03 |
| Normal-vs-Age(41-60Yrs) |
5.993900E-02 |
| Normal-vs-Age(61-80Yrs) |
1.062570E-03 |
| Normal-vs-Age(81-100Yrs) |
3.043800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.415800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.543600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.503200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.505040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.256000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.017200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.060600E-01 |
| Normal-vs-Grade 2 |
4.213800E-01 |
| Normal-vs-Grade 3 |
1.299960E-03 |
| Normal-vs-Grade 4 |
1.10150000232068E-10 |
| Grade 1-vs-Grade 2 |
1.002820E-01 |
| Grade 1-vs-Grade 3 |
4.721900E-03 |
| Grade 1-vs-Grade 4 |
1.91890000000861E-06 |
| Grade 2-vs-Grade 3 |
1.216030E-02 |
| Grade 2-vs-Grade 4 |
9.73499947320988E-10 |
| Grade 3-vs-Grade 4 |
3.7477000000008E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.766600E-01 |
| Normal-vs-ccB subtype |
2.7000000013544E-08 |
| ccA subtype-vs-ccB subtype |
1.37789779586228E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.135800E-02 |
| Normal-vs-N1 |
4.21969999999661E-05 |
| N0-vs-N1 |
6.983200E-03 |
|
|
